CIA
BSX icon

Concurrent Investment Advisors’s Boston Scientific BSX Stock Holding History

Concurrent Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$9.54K – 1946
2025
Q4 		$9.54K Hold
100
– – ﹤0.01% 1765
2025
Q3 		$9.76K Hold
100
– – ﹤0.01% 1483
2025
Q2 		$10.7K Buy
+100
New +$10.1K ﹤0.01% 1392

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Concurrent Investment Advisors's BSX Position: Q1 2026 in Review

Concurrent Investment Advisors increased its Boston Scientific (BSX) stake by 6.9% in Q1 2026, buying an estimated $162K and bringing the position to 31,399 shares worth $1.97M. The position accounts for 0.02% of the portfolio, ranked #623.

Concurrent Investment Advisors first reported a position in BSX in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.8M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Concurrent Investment Advisors held 31,399 shares of Boston Scientific worth $1.97M as of Q1 2026.
  • Concurrent Investment Advisors bought 2,026 Boston Scientific shares in Q1 2026, an estimated $162K.
  • Boston Scientific made up 0.02% of Concurrent Investment Advisors's portfolio in Q1 2026, its #623 holding.
  • Concurrent Investment Advisors first reported a position in Boston Scientific in Q4 2023 and has held it in 10 quarters since.
  • Concurrent Investment Advisors's Boston Scientific position peaked at $2.8M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.